ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,026Medicare Part D Prescriptions Filled, Including Refills

Rank: 36 out of 103

$378K Total Retail Price of All Prescriptions

Rank: 49 out of 103

376 Patients Receiving at Least One Drug in Part D
96%Patients 65 Years and Older
18% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Dakota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 376 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

6% of this provider’s 376 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

1% of this provider’s 10,766 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$34 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Dakota
SIMVASTATIN 649 632 1 2
LEVOTHYROXINE SODIUM 622 618 2 1
HYDROCHLOROTHIAZIDE 463 450 3 16
AMLODIPINE BESYLATE 445 440 4 6
LOSARTAN POTASSIUM 417 415 5 12
LISINOPRIL 386 379 6 5
OMEPRAZOLE 375 368 7 3
METOPROLOL SUCCINATE 329 319 8 8
ATORVASTATIN CALCIUM 305 287 9 18
FUROSEMIDE 300 300 10 4
METOPROLOL TARTRATE 292 291 11 9
WARFARIN SODIUM 276 275 12 7
ATENOLOL 259 249 13 14
METFORMIN HCL 179 161 14 13
POTASSIUM CHLORIDE 178 175 15 10
DONEPEZIL HCL 177 177 16 28
ALLOPURINOL 169 169 17 26
SERTRALINE HCL 158 138 18 21
TAMSULOSIN HCL 129 129 19 23
PRAVASTATIN SODIUM 125 125 20 33
CLOPIDOGREL 112 112 21 32
TRAZODONE HCL 110 110 22 52
TRIAMTERENE-HCTZ 106 106 23 38
GABAPENTIN 102 102 24 22
ALENDRONATE SODIUM 95 95 25 19
HYDROCODONE-ACETAMINOPHEN 92 92 S3 26 11
CARVEDILOL 84 84 27 20
NAMENDA 80 80 28 41
CLONIDINE HCL 77 77 29 82
LANTUS 76 76 30 39
ZETIA 74 74 31 66
TRAMADOL HCL 73 73 32 17
ZOLPIDEM TARTRATE 73 61 32 29
FAMOTIDINE 69 66 34 78
CRESTOR 68 68 35 27
KLOR-CON 10 68 68 35 45
FINASTERIDE 58 58 37 69
ISOSORBIDE MONONITRATE ER 58 58 37 37
GLIMEPIRIDE 58 58 37 50
RAMIPRIL 57 57 40 126
FENTANYL 54 54 S2 41 34
PLAVIX 52 52 42 46
NITROGLYCERIN PATCH 51 51 43 89
SYNTHROID 50 50 44 51
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 12, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.